Covalence Health brings deep healthcare expertise and rigorous analytical frameworks to support investors throughout the due diligence process, helping validate valuations and stress-test market assumptions before capital is deployed. Our team has evaluated targets across every segment of the U.S. healthcare industry—from providers and payers to digital health platforms and healthcare services—and we understand the regulatory complexities, reimbursement dynamics, and competitive forces that drive value creation in each segment.

Through comprehensive qualitative research, including interviews with customers, competitors, and industry experts, combined with detailed market and financial analysis, we uncover the insights that matter most: Is the growth story real? Are the unit economics sustainable? What risks could derail the thesis? Critically, we don't evaluate targets in isolation—we assess how an acquisition fits within the broader portfolio strategy, identifying synergies, potential conflicts, and strategic positioning that determine true value to the investor.

Investors choose us because we move quickly without sacrificing rigor, communicate findings clearly without jargon, and deliver actionable recommendations rather than just data dumps—helping them make confident decisions in compressed timeframes.